Identification of triazolyl KAT6 inhibitors via a templated fragment approach
- 3 September 2024
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 113, 129948
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerCell Chemical Biology, 2023
- The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitorsPharmacological Research, 2021
- MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathwayOncogene, 2015
- The Chemical Space ProjectAccounts of Chemical Research, 2015
- KATs in cancer: functions and therapiesOncogene, 2015
- Chromatin remodeling in Cancer: A Gateway to regulate gene TranscriptionMolecular Oncology, 2012
- Virtual Exploration of the Chemical Universe up to 11 Atoms of C, N, O, F: Assembly of 26.4 Million Structures (110.9 Million Stereoisomers) and Analysis for New Ring Systems, Stereochemistry, Physicochemical Properties, Compound Classes, and Drug DiscoveryJournal of Chemical Information and Modeling, 2007
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004
- A ‘Rule of Three’ for fragment-based lead discovery?Drug Discovery Today, 2003
- Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug DiscoveryJournal of Chemical Information and Computer Sciences, 2001